Form D · Biotechnology
Bolt Biotherapeutics, Inc.
Redwood City, CA · CIK 0001641281
Offering snapshot reported Jun 7, 2021 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2021 | Initial | $15,000,000 | No comparison | Not reported | SEC filing |
| Jan 28, 2021 | Initial | $93,499,984 | No comparison | 17 | SEC filing |
| Jul 15, 2019 | Initial | $40,103,799 | No comparison | 11 | SEC filing |
| Aug 6, 2018 | Initial | $13,385,363 | No comparison | 11 | SEC filing |
| Feb 20, 2018 | Initial | $6,000,002 | No comparison | 6 | SEC filing |
| Sep 30, 2016 | Initial | $9,999,998 | No comparison | 6 | SEC filing |
| May 7, 2015 | Initial | $600,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-402021
Source: Form D, filed Jun 7, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Bisgaard | Director |
| David Dornan | Executive |
| Edgar Engleman | Director |
| Ken Harrison | Director |
| James Healy | Director |
| Ashish Khanna | Director |
| Kathleen La Porte | Director |
| Reiner Laus | Director, Executive |
| Chih Ping Liu | Director, Executive, Promoter |
| Richard Miller | Director |
| Peter Moldt | Director |
| Edith Perez | Executive |
| William Quinn | Executive |
| Randall Schatzman | Director, Executive |
| Mahendra Shah | Director |
| Grant Yonehiro | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
900 Chesapeake Drive
Redwood City, CA, 94063
Redwood City, CA, 94063